These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 28904127)

  • 1. Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection.
    Wan SW; Chen PW; Chen CY; Lai YC; Chu YT; Hung CY; Lee H; Wu HF; Chuang YC; Lin J; Chang CP; Wang S; Liu CC; Ho TS; Lin CF; Lee CK; Wu-Hsieh BA; Anderson R; Yeh TM; Lin YS
    J Immunol; 2017 Oct; 199(8):2834-2844. PubMed ID: 28904127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.
    Wan SW; Lu YT; Huang CH; Lin CF; Anderson R; Liu HS; Yeh TM; Yen YT; Wu-Hsieh BA; Lin YS
    PLoS One; 2014; 9(3):e92495. PubMed ID: 24658118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection.
    Kao YS; Yu CY; Huang HJ; Tien SM; Wang WY; Yang M; Anderson R; Yeh TM; Lin YS; Wan SW
    J Immunol; 2019 Oct; 203(7):1909-1917. PubMed ID: 31451673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).
    Gelanew T; Poole-Smith BK; Hunsperger E
    J Virol Methods; 2015 Sep; 222():214-23. PubMed ID: 26070890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
    Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
    J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage.
    Chao CH; Wu WC; Lai YC; Tsai PJ; Perng GC; Lin YS; Yeh TM
    PLoS Pathog; 2019 Apr; 15(4):e1007625. PubMed ID: 31009511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model.
    Tien SM; Chang PC; Lai YC; Chuang YC; Tseng CK; Kao YS; Huang HJ; Hsiao YP; Liu YL; Lin HH; Chu CC; Cheng MH; Ho TS; Chang CP; Ko SF; Shen CP; Anderson R; Lin YS; Wan SW; Yeh TM
    PLoS Pathog; 2022 Apr; 18(4):e1010469. PubMed ID: 35486576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).
    Gelanew T; Hunsperger E
    Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype-specific anti-Dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production.
    Masrinoul P; Omokoko MD; Pambudi S; Ikuta K; Kurosu T
    Viral Immunol; 2013 Aug; 26(4):250-8. PubMed ID: 23941673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-dengue virus nonstructural protein 1 antibodies contribute to platelet phagocytosis by macrophages.
    Wan SW; Yang YW; Chu YT; Lin CF; Chang CP; Yeh TM; Anderson R; Lin YS
    Thromb Haemost; 2016 Mar; 115(3):646-56. PubMed ID: 26632672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency.
    Chen MC; Lin CF; Lei HY; Lin SC; Liu HS; Yeh TM; Anderson R; Lin YS
    J Immunol; 2009 Aug; 183(3):1797-803. PubMed ID: 19592650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-dengue virus nonstructural protein 1 antibodies cause NO-mediated endothelial cell apoptosis via ceramide-regulated glycogen synthase kinase-3β and NF-κB activation.
    Chen CL; Lin CF; Wan SW; Wei LS; Chen MC; Yeh TM; Liu HS; Anderson R; Lin YS
    J Immunol; 2013 Aug; 191(4):1744-52. PubMed ID: 23851680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients.
    Omokoko MD; Pambudi S; Phanthanawiboon S; Masrinoul P; Setthapramote C; Sasaki T; Kuhara M; Ramasoota P; Yamashita A; Hirai I; Ikuta K; Kurosu T
    Am J Trop Med Hyg; 2014 Jul; 91(1):146-55. PubMed ID: 24778195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue Virus Nonstructural Protein 1-Induced Antibodies Cross-React with Human Plasminogen and Enhance Its Activation.
    Chuang YC; Lin J; Lin YS; Wang S; Yeh TM
    J Immunol; 2016 Feb; 196(3):1218-26. PubMed ID: 26712948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.
    Huang HJ; Yang M; Chen HW; Wang S; Chang CP; Ho TS; Kao YS; Tien SM; Lin HH; Chang PC; Lai YC; Hsiao YP; Liu YL; Chao CH; Anderson R; Yeh TM; Lin YS; Wan SW
    Vaccine; 2022 Apr; 40(15):2299-2310. PubMed ID: 35287985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
    Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
    Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avian anti-NS1 IgY antibodies neutralize dengue virus infection and protect against lethal dengue virus challenge.
    O'Donnell KL; Espinosa DA; Puerta-Guardo H; Biering SB; Warnes CM; Schiltz J; Nilles ML; Li J; Harris E; Bradley DS
    Antiviral Res; 2020 Nov; 183():104923. PubMed ID: 32979401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis.
    Falconar AK
    Arch Virol; 1997; 142(5):897-916. PubMed ID: 9191856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection.
    Lai YC; Chuang YC; Liu CC; Ho TS; Lin YS; Anderson R; Yeh TM
    Sci Rep; 2017 Aug; 7(1):6975. PubMed ID: 28765561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines.
    Falconar AK
    Clin Vaccine Immunol; 2008 Mar; 15(3):549-61. PubMed ID: 18160621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.